ATE242626T1 - Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält - Google Patents

Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält

Info

Publication number
ATE242626T1
ATE242626T1 AT01204432T AT01204432T ATE242626T1 AT E242626 T1 ATE242626 T1 AT E242626T1 AT 01204432 T AT01204432 T AT 01204432T AT 01204432 T AT01204432 T AT 01204432T AT E242626 T1 ATE242626 T1 AT E242626T1
Authority
AT
Austria
Prior art keywords
water
effortable
excluding
forms
dosage form
Prior art date
Application number
AT01204432T
Other languages
English (en)
Inventor
Alberto Reiner
Giorgio Reiner
Original Assignee
Applied Pharma Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Pharma Res filed Critical Applied Pharma Res
Application granted granted Critical
Publication of ATE242626T1 publication Critical patent/ATE242626T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01204432T 2001-11-20 2001-11-20 Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält ATE242626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204432A EP1312355B1 (de) 2001-11-20 2001-11-20 Wasserlösliche pharmazeutische Darreichungsform, ausgenommen Brause-Formen, welche nicht-steroidale antientzündliche Wirkstoffe enthält

Publications (1)

Publication Number Publication Date
ATE242626T1 true ATE242626T1 (de) 2003-06-15

Family

ID=8181265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01204432T ATE242626T1 (de) 2001-11-20 2001-11-20 Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält

Country Status (9)

Country Link
EP (1) EP1312355B1 (de)
AT (1) ATE242626T1 (de)
AU (1) AU2002356685A1 (de)
BR (1) BR0206371A (de)
DE (1) DE60100364T2 (de)
DK (1) DK1312355T3 (de)
ES (1) ES2199916T3 (de)
PT (1) PT1312355E (de)
WO (1) WO2003043600A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100567131B1 (ko) * 2004-01-05 2006-04-05 신일제약주식회사 쓴맛을 차폐한 아르기닌 함유 이부프로펜 경구투여 액상조성물
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US7776318B2 (en) 2004-11-26 2010-08-17 L'oreal S.A. Liquid cleaning composition comprising at least one anionic surfactant and its use for cleansing human keratin materials
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
EP3508199A1 (de) * 2018-01-05 2019-07-10 Dompé farmaceutici S.p.A. Schnell freisetzende pharmazeutische zusammensetzungen mit ketoprofen-lysinsalz
US11260026B2 (en) 2018-12-14 2022-03-01 Apr Applied Pharma Research Sa Ready to use diclofenac stick packs
IL298861A (en) 2020-06-10 2023-02-01 Applied Pharma Res Sugar-based diclofenac preparations are bioavailable

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat

Also Published As

Publication number Publication date
DE60100364T2 (de) 2003-12-04
DE60100364D1 (de) 2003-07-31
BR0206371A (pt) 2003-12-23
ES2199916T3 (es) 2004-03-01
DK1312355T3 (da) 2003-10-06
EP1312355B1 (de) 2003-06-11
WO2003043600A1 (en) 2003-05-30
EP1312355A1 (de) 2003-05-21
AU2002356685A1 (en) 2003-06-10
PT1312355E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
CA2484514A1 (en) Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
EP1444984B1 (de) Topische pharmazeutische Zusammensetzungen enthaltend aktive natürliche Bestandteile zur Verhütung und Behandlung von mucosalen Entzündungprozessen
KR970705975A (ko) 단위 생약제제로서의 타블랫형 비타민과 칼슘 복합치료제제와 이의 제조방법 및 용도(therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof)
AU2002330645B2 (en) Composition comprising paracetamol and a bitterness masking component
JP2014208652A (ja) 発泡性組成物
ES2032681T3 (es) Una composicion farmaceutica anti-inflamatoria, con eliminacion, en solucion, de sabor amargo, ardor de la garganta y toxicidad intestinal. (reserva del art. 167.2 cpe).
ATE242626T1 (de) Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält
JP2006316009A (ja) 口腔内貼付剤及びその製造方法
JP2006347958A (ja) 咽頭粘膜抗炎症スプレー剤
KR101122174B1 (ko) 비스테로이드성 소염제를 포함하며 우수한 기호성을 가진약학적 경구 제제
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
WO2016102708A1 (en) Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol
CA2429793A1 (en) Interferon therapeutic effect enhancer
GB2327041A (en) Topical Analgesic Composition
JP4084329B2 (ja) 液状組成物およびその製造方法
KR19980703866A (ko) 인후용 살균소독약
PL201844B1 (pl) Musujący środek farmaceutyczny zawierający metamizol
AR015531A1 (es) Composicion farmaceutica oral, concentrado farmaceutico y proceso para prepararlo
JP2023147254A (ja) 口内炎発症抑制組成物
WO2014027976A1 (en) Topical aqueous pharmaceutical compositions of flurbiprofen and chlorhexidine
BG61892B2 (bg) Състав на основата на ибупрофен за орална употреба
AR034701A1 (es) Nuevas composiciones farmaceuticas con accion antidiabetica y proceso para su preparacion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1312355

Country of ref document: EP